98 related articles for article (PubMed ID: 22335555)
1. 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.
Ramnauth J; Renton P; Dove P; Annedi SC; Speed J; Silverman S; Mladenova G; Maddaford SP; Zinghini S; Rakhit S; Andrews J; Lee DK; Zhang D; Porreca F
J Med Chem; 2012 Mar; 55(6):2882-93. PubMed ID: 22335555
[TBL] [Abstract][Full Text] [Related]
2. Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.
Annedi SC; Ramnauth J; Maddaford SP; Renton P; Rakhit S; Mladenova G; Dove P; Silverman S; Andrews JS; Felice MD; Porreca F
J Med Chem; 2012 Jan; 55(2):943-55. PubMed ID: 22175766
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.
Annedi SC; Maddaford SP; Ramnauth J; Renton P; Rybak T; Silverman S; Rakhit S; Mladenova G; Dove P; Andrews JS; Zhang D; Porreca F
Eur J Med Chem; 2012 Sep; 55():94-107. PubMed ID: 22840695
[TBL] [Abstract][Full Text] [Related]
4. First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.
Mladenova G; Annedi SC; Ramnauth J; Maddaford SP; Rakhit S; Andrews JS; Zhang D; Porreca F
J Med Chem; 2012 Apr; 55(7):3488-501. PubMed ID: 22420844
[TBL] [Abstract][Full Text] [Related]
5. Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain.
Annedi SC; Maddaford SP; Mladenova G; Ramnauth J; Rakhit S; Andrews JS; Lee DK; Zhang D; Porreca F; Bunton D; Christie L
J Med Chem; 2011 Oct; 54(20):7408-16. PubMed ID: 21923116
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.
Ramnauth J; Speed J; Maddaford SP; Dove P; Annedi SC; Renton P; Rakhit S; Andrews J; Silverman S; Mladenova G; Zinghini S; Nair S; Catalano C; Lee DK; De Felice M; Porreca F
J Med Chem; 2011 Aug; 54(15):5562-75. PubMed ID: 21699209
[TBL] [Abstract][Full Text] [Related]
7. Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.
Payne JE; Bonnefous C; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
J Med Chem; 2010 Nov; 53(21):7739-55. PubMed ID: 20931971
[TBL] [Abstract][Full Text] [Related]
8. Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).
Annedi SC; Ramnauth J; Cossette M; Maddaford SP; Dove P; Rakhit S; Andrews JS; Porreca F
Bioorg Med Chem Lett; 2012 Apr; 22(7):2510-3. PubMed ID: 22370270
[TBL] [Abstract][Full Text] [Related]
9. Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma.
Huang H; Li H; Yang S; Chreifi G; Martásek P; Roman LJ; Meyskens FL; Poulos TL; Silverman RB
J Med Chem; 2014 Feb; 57(3):686-700. PubMed ID: 24447275
[TBL] [Abstract][Full Text] [Related]
10. Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.
van der Stelt M; Cals J; Broeders-Josten S; Cottney J; van der Doelen AA; Hermkens M; de Kimpe V; King A; Klomp J; Oosterom J; Pols-de Rooij I; de Roos J; van Tilborg M; Boyce S; Baker J
J Med Chem; 2011 Oct; 54(20):7350-62. PubMed ID: 21923175
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors.
Pajouhesh H; Feng ZP; Zhang L; Pajouhesh H; Jiang X; Hendricson A; Dong H; Tringham E; Ding Y; Vanderah TW; Porreca F; Belardetti F; Zamponi GW; Mitscher LA; Snutch TP
Bioorg Med Chem Lett; 2012 Jun; 22(12):4153-8. PubMed ID: 22579422
[TBL] [Abstract][Full Text] [Related]
12. 2,4-Diaminothienopyrimidines as orally active antimalarial agents.
González Cabrera D; Le Manach C; Douelle F; Younis Y; Feng TS; Paquet T; Nchinda AT; Street LJ; Taylor D; de Kock C; Wiesner L; Duffy S; White KL; Zabiulla KM; Sambandan Y; Bashyam S; Waterson D; Witty MJ; Charman SA; Avery VM; Wittlin S; Chibale K
J Med Chem; 2014 Feb; 57(3):1014-22. PubMed ID: 24446664
[TBL] [Abstract][Full Text] [Related]
13. Selenophene-containing inhibitors of type IIA bacterial topoisomerases.
Wiles JA; Phadke AS; Bradbury BJ; Pucci MJ; Thanassi JA; Deshpande M
J Med Chem; 2011 May; 54(9):3418-25. PubMed ID: 21443219
[TBL] [Abstract][Full Text] [Related]
14. 1,4-Dihydroindeno[1,2-c]pyrazoles with acetylenic side chains as novel and potent multitargeted receptor tyrosine kinase inhibitors with low affinity for the hERG ion channel.
Dinges J; Albert DH; Arnold LD; Ashworth KL; Akritopoulou-Zanze I; Bousquet PF; Bouska JJ; Cunha GA; Davidsen SK; Diaz GJ; Djuric SW; Gasiecki AF; Gintant GA; Gracias VJ; Harris CM; Houseman KA; Hutchins CW; Johnson EF; Li H; Marcotte PA; Martin RL; Michaelides MR; Nyein M; Sowin TJ; Su Z; Tapang PH; Xia Z; Zhang HQ
J Med Chem; 2007 May; 50(9):2011-29. PubMed ID: 17425296
[TBL] [Abstract][Full Text] [Related]
15. Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.
Bregman H; Berry L; Buchanan JL; Chen A; Du B; Feric E; Hierl M; Huang L; Immke D; Janosky B; Johnson D; Li X; Ligutti J; Liu D; Malmberg A; Matson D; McDermott J; Miu P; Nguyen HN; Patel VF; Waldon D; Wilenkin B; Zheng XM; Zou A; McDonough SI; DiMauro EF
J Med Chem; 2011 Jul; 54(13):4427-45. PubMed ID: 21634377
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases.
Butini S; Brindisi M; Gemma S; Minetti P; Cabri W; Gallo G; Vincenti S; Talamonti E; Borsini F; Caprioli A; Stasi MA; Di Serio S; Ros S; Borrelli G; Maramai S; Fezza F; Campiani G; Maccarrone M
J Med Chem; 2012 Aug; 55(15):6898-915. PubMed ID: 22779702
[TBL] [Abstract][Full Text] [Related]
17. 3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors.
Annedi SC; Maddaford SP; Ramnauth J; Renton P; Speed J; Rakhit S; Andrews JS; Porreca F
Bioorg Med Chem Lett; 2012 Mar; 22(5):1980-4. PubMed ID: 22318159
[TBL] [Abstract][Full Text] [Related]
18. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
19. Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.
Huang H; Silverman RB
Curr Top Med Chem; 2013; 13(7):803-12. PubMed ID: 23578024
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management.
Nelson DW; Frost JM; Tietje KR; Florjancic AS; Ryther K; Carroll WA; Dart MJ; Daza AV; Hooker BA; Grayson GK; Fan Y; Garrison TR; El-Kouhen OF; Yao B; Pai M; Chandran P; Zhu C; Hsieh GC; Meyer MD
Bioorg Med Chem Lett; 2012 Apr; 22(7):2604-8. PubMed ID: 22370265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
